Gummies Week · UP TO 75% OFF UP TO 75% OFF · Gummies Week Ends in This week only · 76 gummies picks marked down Shop the deals →
Go back
Refer for $20
$20
Refer
Get $20 in Chowcash when you refer friends, stores, and brands to Chow420. Your friends also get $20 towards their first purchase when they accept your invitation.
Login to Refer

Hemp News, Laws & Product Updates

A curated news hub focused on hemp regulation and policy changes, cannabinoids (CBD/Delta-8/Delta-9/hemp-derived THC), lab testing and COAs, product safety, brands, and industry trends.

  • Federal & State Hemp Laws
  • THC Policy
  • CBD / Delta-8
  • Compliance
  • Lab Testing (COA)
  • Product Safety
  • Industry & Brands
Back to Chow420
https://hightimes.com/

Humboldt Weed Grower To Pay $750,000 for Environmental Violations

A Humboldt County cannabis grower will pay at least $750,000 to settle a dispute with state water and wildlife agencies over alleged environmental violations at a 435-acre cultivation site in California’s famed Emerald Triangle. In the settlement agreement, licensed weed grower Joshua Sweet and his companies, The Hills LLC and Shadow Light Ranch LLC, admitted to violations of state water regulations over a period of several years.  “It is critical for all cannabis cultivators to be environmentally responsible and protect California’s water supply and water quality,” Taro Murano, program manager for the State Water Board’s Division of Water Rights cannabis enforcement section, said in a statement from the California Department of Fish and Wildlife (CDFW). “Sweet chose to operate his business while ignoring regulations designed to protect the environment. He must now remediate the environmental damage he caused and pay a significant penalty. No one should get a business advantage by ignoring the law and harming the environment.” The settlement calls for Sweet to pay $1.75 million for the violations, which include illegally diverting and collecting water from unnamed tributaries of the South Fork Eel River that cross the property. According to the settlement terms, $1 million of the fine was suspended, but Sweet will be responsible for paying the additional $1 million if remediations to the property are not completed as agreed. The settlement cites several violations, including building an unpermitted pond on a waterway to collect water for irrigating cannabis plants. Other violations include the destruction of wetland habitats and stream channels, converting oak woodland to cannabis cultivation and failure to work with state and local officials to satisfy permitting requirements. Yvonne West, director of the State Water Resources Control Board’s office of enforcement, said that Sweet and his companies did not have the authority to divert water on the property and use it for cannabis cultivation. According to an email from the water board to nonprofit news outlet CalMatters, Sweet took about 16.2 acre-feet of water, approximately enough to supply about 49 households for a year, for a total of three ponds on the property between 2017 and 2020. “This case represents years of hard work by dedicated staff to remediate damage to streambed channels, wetland habitat and oak woodlands,” said Nathaniel Arnold, acting chief of law enforcement for CDFW. “The settlement also speaks volumes to the egregious nature of this case and should send a strong message to those working outside of state regulations to cultivate cannabis. Our natural resources deserve to be respected.” Included in the settlement agreement is a $500,000 payment for water rights violations, a record penalty for such a violation in the state of California. The defendants are also required to remove unpermitted ponds and restore wetlands and waterways as part of the agreement. Sweet believes that the fines are unfair and excessive and that the case could have been handled differently. “If the full penalty and remediation costs were due today it would take everything I own,” Sweet said in a statement to CalMatters. “Although I will follow through with my end of the settlement, I do not believe this is fair or just, and I believe I have already suffered way too much,” Sweet said in the emailed statement.  “Even during our court-mandated settlement conference, they were asked why they would go after a small independent businessman with these type of enormous fines usually reserved for huge corporations that destroy ecosystems,” he added. But state and local officials defended the settlement, saying it is justified by the actions taken at the property. “The ordered penalties are modest given the scope of damage, the length of time the site has been left unremediated and considering the unjust enrichment or benefit to Mr. Sweet from running a business for several years without going through the necessary permitting process,” said Jeremy Valverde, assistant chief counsel at the California Department of Fish and Wildlife, in a statement emailed to CalMatters. Joshua Curtis, the North Coast Regional Water Quality Control Board’s assistant executive officer, said that Sweet and his businesses “for years resisted our attempts to cooperatively work on restoration and recovery of those resources, leaving formal enforcement as our only option.” “This was an ongoing use by Mr. Sweet and the penalties are over an approximately four-year period for unauthorized diversion and use of water to support cultivation,” said West of the water board. “Five hundred dollars a day, multiple violations over a four-year period, does really add up. And then again we did have the additional types of violations at play here as well.”

https://hightimes.com/

Germany’s Coalition Government Reaches Deal on Weed Legalization

The groups that form Germany’s coalition government struck a deal last week on cannabis legalization, setting the stage for the new law to take effect in the spring.  Now, the proposal will be considered by the country’s parliament, with a vote expected later this month. Zeit, a German publication, reported last week that the “government coalition made up of the SPD, Greens and FDP has agreed on the details of the legalization of cannabis,” and that the “law could come into force on April 1st, but must first be approved by the Bundestag and Bundesrat.”  According to the outlet, Karl Lauterbach, Germany’s federal health minister, “is aiming for approval in parliament in the week from February 19th to 23rd.” In a post on X last week, Lauterbach hailed the agreement by the groups within the coalition. “The fight against the black market, decriminalization and better protection of minors will come as announced. The previous drug policy has failed, a new beginning,” Lauterbach said. The agreement keeps the country on course that the so-called “Traffic Light coalition” laid out late last year.  In November, the SPD, Greens and FDP said they had reached a breakthrough in their negotiations of the new cannabis law.  “The #Cannabis law is coming! Finally: We are finally ending the failed ban policy! After intensive negotiations, there is now a law that focuses on youth and health protection, ends criminalization and is practical,” the Green Party’s spokesperson Kirsten Kappert-Gonther said in a post on social media at the time. According to Forbes, the “path to legalization in Germany has encountered several hurdles,” including the coalition government having to “revise its plan, which initially involved the sale of cannabis, as it risked breaching EU laws.” Forbes reported that the coalition also “confronted criticism from opposition parties seeking to obstruct the proposed legislation,” as well as “internal dissent within the government, particularly from the SPD, emerged regarding the details of the bill.” The outlet Legal Tribune Online said that the agreement last week signaled that “resistance from the ranks of the SPD parliamentary group against the Cannabis Act (CanG) has apparently been overcome.” Late last year, Legal Tribune Online reported that “health politician Dirk Heidenblut MdB, who is responsible for the issue of cannabis in the SPD parliamentary group, announced over the weekend via social media that the final reading of the Cannabis Act (CanG), which was actually planned for the last week of the year, was taking place. does not come about.”  “The reason: The leadership of his SPD parliamentary group expressed concerns about the set-up. The avowed legalization friend explained in a video that he could not understand this, but the implementation would now be postponed until next year. Heidenblut did not want to reveal any further details,” the outlet reported at the time. “The short-term veto of the SPD parliamentary group against the final resolution surprised not only the so-called cannabis community, but also the coalition partners.” Kappert-Gonther said at the time that it was “extremely unfortunate that cannabis is not on the agenda so far,” and that passage of the reform “would have been possible.” But last week’s agreement by the parties indicates that those disagreements have been resolved, and that Germany is now set to enter a new era of cannabis legalization. In a statement, the leaders of the coalition said that the “regulations are a real milestone for a modern drug policy that strengthens prevention and improves health, child and youth protection,” as quoted by Legal Tribune Online. According to Forbes, the agreement “clears the path for the legalization of cannabis for personal use, aligning with the impending vote,” and that, absent any additional delays, “Germany is poised to become the third European Union member state to legalize cannabis for personal use, following Malta and Luxembourg.” “For the government coalition, the legalization of cannabis for personal use marks a significant milestone in modern drug policy, emphasizing prevention and improving health and child and youth protection,” Forbes reported. “However, the proposed legislation, introduced last year by Federal Health Minister Karl Lauterbach, may undergo additional slight revisions to address concerns raised by the SPD, potentially involving the expansion and acceleration of monitoring and reporting obligations related to the illicit market.” Forbes said that lawmakers “recently revised the bill to ease restrictions opposed by advocates and supporters in the Bundestag,” with changes including “raising home possession limits and eliminating the possibility of jail time for slightly exceeding the possession limit.” “The government coalition also plans to introduce a complementary measure establishing pilot programs for commercial sales, set to be revealed after submission to the European Commission,” Forbes said, adding that, if the proposal passes the parliament in the next two months as expected, the ban on pot will be lifted by April 1, and that adults will be able to “grow cannabis at home and possess small quantities, while cannabis clubs will be allowed from July 1.”

https://hightimes.com/

Travis Barker Talks Moving into Adult-Use Space, Touring, and Barker Canna Co.

Today Travis Barker—the lauded drummer of recently reunited Blink-182, Transplants, Goldfinger, and more—announced the launch of Barker Canna Co., after founding CBD brand Barker Wellness last April. The concept is to provide quality cannabis products that are capable of promoting both creativity and wellness, and the rigors of touring pushed Barker into the potent side of the cannabis space.  Barker Canna Co. initially launched in California at The Syndicate dispensary locations with plans to expand throughout the state. The company will likely expand in other states with legal cannabis markets in 2024. The Barker Canna Co. will roll out everything from live rosin and full-gram vapes, gummies, and mini-infused pre-rolls. The vape hardware for the live rosin and full-gram vape products was developed by Jupiter Research, known experts in the field.  Hemp-derived products are regulated entirely differently from adult-use cannabis products in California. So what in fact prompted Barker’s decision to move from hemp-derived CBD products to state-legal potent cannabis? “The decision to expand from hemp-derived CBD products to state-legal potent cannabis was driven by a strategic response to the evolving cannabis landscape and consumer preferences,” Barker tells High Times.  Things have been good lately for the drummer: Last month, Barker kicked off the Emmys—something he’s been waiting “all his life” to do, performing Phil Collins’s “In the Air Tonight” along with an entourage of performers, Anthony Anderson and a choir from Compton, California. Blink-182’s “All the Small Things” just hit one billion streams on Spotify, joining the “Billion Club.” The band’s last album One More Time was released on Oct. 20, 2023, prompting an extended world tour. Cannabis became the answer to a life constantly on the road, he explained, and part of it was about his own recovery process. The momentous, four-leg Blink-182 reunion world tour will take Barker from Madrid to Melbourne by the time it’s over. This means nearly 100 shows, over 40 in North America and dozens more in Europe, Latin American, and Oceania—imagine the toll that level of touring would take on a person’s body. “Initially seeking balance amid a chaotic lifestyle, cannabis, especially edibles, became my recovery go-to,” Barker says. “For me personally, it’s about aligning mentally and physically with my chosen lifestyle. Today, my relationship with cannabis is sophisticated, focusing on balance, creativity, well-being, and positive vibes. Barker Canna Co. is born from this journey, offering quality products to share what I’ve learned.”  The brand features items like vegan and gluten-free Mini Peanut Butter Cups or hard-hitting Live Rosin All-In-One Vapes. But one thing that stood out to us are the Barkies—packs of five mini pre-rolls dipped in kief. These come in strains like Rainbow OG Popsicle or Blackberry Diesel. He plans on expanding Barker Canna Co. products to other state-legal cannabis markets in the near future. It’s a state-by-state process different from selling hemp-derived products legal under the 2018 Farm Bill. “California is our starting point, laying down the groundwork for our brand,” Barker says. We plan to expand throughout the state and other legalized states in 2024 so stay tuned. We’re keeping it flexible and ready for whatever comes our way.”  Occasionally High Times staff goes to The Syndicate—some locations having a false library wall for a pretty badass retro speakeasy aesthetic. The velvet-lined walls take you back 100 years to the Roaring ‘20s. It’s a vibe if you’ve never been to one. “I’ve been going to The Syndicate for years,” Barker recalls. “They have an incredible team and amazing product selection. As a result, they have become my go-to trustworthy cannabis retailer. Their vibe is really cool and I always have the best experience going into their stores.” Barker and Blink-182 are currently on the Australia leg of their tour, so there’s a lot more work to do, and a lot more recovery. Barker was only about 17 and a known stoner in school when Blink-182 formed, long before fame, marrying a Kardashian, and reality television. And the last time the original line-up of Blink-182 performed was in 2014—a decade ago. So what will he do to prepare for the tour? “My prep work for touring looks a lot different than it used to!” Barker, 48, laughs. “I try to stay as active as possible and make sure I really take care of myself and recover when I have down time. Using the Barker Wellness and Barker Canna Co. products helps with this journey—whether it’s to alleviate muscle pain or spark creativity. Maintaining stamina and strength is crucial for what I do so I’m constantly practicing so I can perform at my best.” Visit a The Syndicate location throughout California to find Barker Canna Co., developed in part by Barker.

https://hightimes.com/

LGBTQ+ Advocates Call Out LCB in Recent Raids at Gay Bars

A group of gay bar owners and LGBTQ+ advocates recently released a joint statement regarding recent “visits,” which they describe as raids, conducted by the Washington State Liquor and Cannabis Control Board (LCB) at their businesses in the Capitol Hill neighborhood. The LCB told bar owners on Jan. 26 and 27 that law enforcement observed violations of the law often called the “lewd conduct law,” which requires employees and patrons to clothe specific parts of their bodies. A coalition of these advocates release a statement on Instagram on Jan. 29 about the raids, including Joey Burgess (The Cuff Complex and Queer/Bar), Keth Christensen (The Seattle Eagle), Kevin Kauer (Massive), Dan Savage (podcast host and author), Terry Miller (founder of the It Gets Better Project alongside his husband, Savage), and Kurt Olivo, and called on advocates to attend an LCB meeting on Jan. 30. “We are issuing this statement to express our concern over recent events targeting gay men. Specifically, unjust raids were conducted by the Joint Enforcement Team (JET) and the Liquor Control Board at several historic gay bars, by extension threatening all active LGBTQ nightlife venues,” the statement said. “Our coalition consists of establishments that provide safe spaces for diverse and marginalized communities to express themselves through love, music, dance, and art. The recent raids have disrupted these operations and undermined trust and security within our community.” The statement continued to explain that none of the venues within the coalition have ever previously been cited for alcohol or violent offenses, and at most, citations related to an individual’s clothing, such as “being shirtless or wearing a jockstrap.” Furthermore, raids on LGBTQ+ businesses have historically persecuted marginalized communities in their safe spaces, and the most recent events cause the relationship between the LGBTQ+ community and law enforcement to be challenged. In response, the coalition statement called for an investigation into the LCB raids. “Our coalition remains committed to fostering positive relations with all stakeholders, emphasizing the need for mutual respect and an understanding of the unique challenges faced by gay, and by extension, LGBTQ+ community as a whole,” the statement concluded. “This statement serves as a call for justice, equality, and the protection of the rights and dignity of our community members.” The coalition, alongside other residents and advocates, attended an LCB meeting on Jan. 30, where members of the community called out the LCB. “These were raids. Stop calling them visits. If everyone in a bar leaves when you show up, 10 of you in uniform with flashlights, they are not experiencing your presence as a social call,” Savage said. “The message sent was if they are raiding gay bars in Seattle, if they are harassing gay men for being shirtless in gay bars in Seattle, we are winning—the bigots are winning.” According to King5, the LCB also had individuals taking photographs in the bars to obtain evidence of “lewd conduct.” The LCB investigators didn’t make their visit or their identity known to business owners or patrons at the time. “Taking pictures without consent of gay men and then posting those pictures as evidence is immoral,” said an unnamed speaker at the meeting. Savage described the LCB raid as a violation, rather than a “visit,” and explained that the photos are subject to the Public Disclosure laws which means they will be released to the public once the investigation has been completed. “Not all the men who go to the Eagle are out of the closet in all areas of their lives. Men could lose their jobs or homes once these photographs are released,” wrote Miller on Instagram on Jan. 31. “LCB officers knew these photos would become a part of the public record. LCB officers knew each photo they took had the potential to ‘cause harm to the depicted person.’” At the meeting, LCB Director David Postman stated that the violations were recorded during the usual enforcement duties conducted by LCB officers. Postman also acknowledged the LCB’s history with the LGBTQ+ community in the past, and he and two other board members agreed to prevent incidents like the raids from happening again. Washington State law, also referred to as the “lewd conduct law,” prohibits such conduct for any business that holds a liquor license, including employees or patrons being unclothed and exposing parts of the body “to view any portion of the breast below the top of the areola or of any portion of the pubic hair, anus, cleft of the buttocks, vulva, or genitals,” among many other examples. King5 wrote that the law was intended to prevent strip clubs from serving alcohol, but Postman commented that changes to the law are being reconsidered in the Washington legislature. “The lewd conduct law, it’s problematic, just talking about my personal point of view here,” Postman said. However, Postman also added that even if the law is archaic, they must continue to enforce it until changes are made. “When there’s laws on the books, it’s really hard to just say ‘Well, we’ve decided not to enforce that one’—the lawmakers, the legislature doesn’t like that, and for good reason,” said Postman. “I can tell you; there is no crackdown on lewd conduct right now, there is no crackdown on gay clubs, there’s no crackdown on clubs in Seattle or anywhere else. We’re doing our normal business here.” LCB board member Jim Vollendroff also spoke at the meeting, ensuring members of the LGBTQ+ community that they will seek a way to prevent it from happening in the future. Likewise, Seattle Mayor Bruce Harrell also issued a statement about the LCB inspections, acknowledging community concerns. “Under my administration, we will not target people or communities based on their sexuality,” Harrell said. “We understand concerns raised by the community based on a perception of violating this principle.” Last year in July, a new cannabis ordinance took effect, which offers labor protections for employees, which “will help provide a stable workplace, stronger workforce, and contribute to a better overall economy for Seattle.”

https://hightimes.com/

Drug Maker Unveils Experimental Drug as Opioid Alternative

A pharmaceutical company unveiled an experimental new drug that is being touted as a less dangerous alternative to opioids. To date, few drugs have demonstrated enough power to manage higher levels of pain often associated with post-surgery recovery. WXYZ Detroit, an ABC affiliate, reports that Vertex Pharmaceuticals said Tuesday the drug’s use in late-stage clinical trials resulted in “clinically meaningful reduction in pain,” without many of the risks associated with opioids. The new drug is called VX-548 and it’s showing promise in early stages. Two trials demonstrated that patients who recently came out of surgery who received Vertex’s new drug had statistically significant pain relief. Phase 2 trial results were published Dec. 13, 2023, noting its effects on painful diabetic peripheral neuropathy. Researchers in a third trial observed a wider range of pain-related conditions. Phase 3 trial results were published on Jan. 30, 2024 and showed “clinically meaningful reduction in pain from baseline in both the abdominoplasty and bunionectomy randomized controlled trials,” as well as many other surgery-related conditions.  Participants who used the drug for up to 14 days also noted positive results, with over 83% of patients saying VX-548 was “good” to “excellent” at managing pain.   Vertex noted VX-548 was “safe and well-tolerated in all three studies,” but it failed to work better than hydrocodone bitartrate/acetaminophen, aka Vicodin. The National Library of Medicine notes that pain is a complex phenomenon, and that one type of painkiller won’t work for all situations. Vertex plans to submit a New Drug Application to the U.S. Food and Drug Administration (FDA) by mid-2024 regarding VX-548’s treatment of moderate-to-severe acute pain. Vertex’s Phase 1-3 trials move the company closer to gaining approvals from the FDA. If they are successful, it could  provide people in the U.S. with another pain treatment option. The vast majority of drug overdoses in the U.S. continues to be dominated by opioids. And to make things worse, the confusion over addiction leads to making it harder for patients who actually need opioids to get them prescribed. According to The National Center for Health Statistics (NCHS) under the U.S. Centers for Disease Control and Prevention, drug overdose deaths rose from 2019 to 2021 with over 106,000 drug overdose deaths reported in 2021. Deaths involving synthetic opioids—primarily fentanyl and excluding methadone—continued its death march with 70,601 overdose deaths reported in 2021. Fentanyl in particular kills 150 Americans per day. Many other attempts to develop alternatives to opioids that effectively dull pain, but they typically fail. If Vertex’s drug is ultimately deemed to be safe, it could introduce a new class of acute pain medicine for the first time in about 20 years, Dr. Jessica Oswald told WXYZ. “As a physician treating patients suffering from pain for many years, I know firsthand the critical need for new, efficacious and safe treatment options,” Oswald said. “The Phase 3 safety and efficacy across the three studies are impressive and demonstrate VX-548’s potential to change the paradigm of pain management.” Opioids kill more Americans than car crashes or gun violence. An alternative to effective, but highly dangerous opioids, some of which having the power to stop breathing, is sorely needed. Bayer introduced heroin in 1898 and called it a “wonder drug” meant to be less addictive than morphine, which was ravaging America at the time with drug addicts. It wasn’t until over 10 years later that an army of heroin addicts emerged. Cannabis itself has been explored as an opioid alternative, but it works in very different ways. One study is taking a closer look at the specific holistic effects that both medical cannabis and opioids provide to get more insight on the efficacy of each substance as it pertains to chronic pain management. The recent study, “The holistic effects of medical cannabis compared to opioids on pain experience in Finnish patients with chronic pain,” was conducted by a team of researchers from Åbo Akademi University, who looked into the effects of medical cannabis and opioids for chronic pain treatment. Published in the Journal of Cannabis Research, the study aimed to take a closer look at how effective medical cannabis is compared to traditional opioids in treating chronic pain, as cannabis use for symptom management has become increasingly more common in recent years. Results suggested that opioids and cannabis are both “equally efficacious” at mitigating pain intensity in patients with chronic pain, while cannabis offered more “holistic” relief in improving sleep, focus and emotional wellbeing. Vertex Pharmaceuticals could help provide a safer alternative compared to typical opioids that have created an epidemic of drug overdoses in the U.S.

https://hightimes.com/

Massachusetts Cannabis Business Owners’ Lawsuit Against the U.S. Government Continues

The saga continues for four Massachusetts-based business owners who filed a lawsuit against the U.S. Justice Department in an attempt to overturn cannabis prohibition. The plaintiffs include owners of Canna Provisions, Inc., Gyasi Sellers, Wiseacre Farm, Inc., and Verano Holdings Corp., who are represented by David Boies and Josh Schiller of Bois Schiller Flexner LLP. The lawsuit was first issued in October 2023, and used the results of a court case from 2005, Gonzales v. Raich, to showcase how federal prohibition of cannabis is outdated. “The federal criminal prohibition on intrastate marijuana remains in place, an unjustified vestige of a long-abandoned policy,” the lawsuit states. “This unjustified intrusion of federal power harms Plaintiffs, threatens the communities they serve, and lacks any rational purpose.” According to a news report published by The Boston Globe, U.S. Attorney General Merrick Garland filed a motion to dismiss the case on Jan. 23, stating that the plaintiffs have no standing on which to sue, and have presented no evidence that prohibition has caused them injury (such as being arrested or prosecuted). The motion stated that “Even if the court were free to disregard Raich ’s holdings (it is not), Plaintiff’s attacks on that holding are unpersuasive,” that the “Plaintiffs lack standing to challenge the CSA [Controlled Substances Act],” and “Courts have consistently, and correctly, held that no fundamental right exists to distribute, possess, or use marijuana.” The Boston Globe noted that the Department of Justice declined to comment, as of Jan. 29. In defense of the business owners, Schiller described how there is evidence that the longstanding illegality of cannabis from a federal standpoint is “well-established.” Schiller cited examples such as cannabis businesses being heavily taxed, forced to pay insurance premiums, cannot take credit cards as a form of payment, and usually pay a higher price for rent or mortgages, “Almost like they are illegal businesses.” James Smith, of Smith, Costello, & Crawford, commented on the lawsuit and told The Boston Globe that winning a case like this one is a “high hill to climb.” Even still, Smith described Massachusetts’ regulatory framework for legalization as “pretty pristine.” The federal government has yet to make a move on federal legalization and has made no constructive decisions regarding major industry issues, such as banking. Smith added that with a lack of action from the federal government, that leaves state legislators to act—and courts are waiting for them to do so. Another comment was provided by Boston University professor and author, Jay Wexler, who told the news outlet that if legislators lose interest in regulating cannabis federally, then expecting the federal government to take on the role of cannabis business in all states “falls apart.” Wexler also stated that this current case could eventually reach the Supreme Court. “These are cases where plaintiffs are aiming for the Supreme Court because there are precedents,” said Wexler. “It’s pretty unlikely that lower courts will feel comfortable agreeing with the plaintiffs.” Schiller estimated that the lawsuit could take two years to reach a conclusion. But one of the plaintiffs, Gyasi Sellers, who owns a delivery service called Treevit, explained that it’s worth the wait. The opportunity to freely and legally take credit cards as a form of payment would improve his entire business, making delivery quicker and also maintaining a safe work environment for employees. Sellers described how prohibition would be “like getting our training wheels taken off, or our handcuffs taken off, depending on how you want to look at it. It’d be nice to say our fate is actually in our hands, and we have the ability to reach our true potential.” The support for putting an end to prohibition continues to grow. Following the recommendation to move cannabis from a Schedule I to a Schedule III substance by the U.S. Department of Health and Human Services, the industry eagerly awaits the decision of the Drug Enforcement Administration. Meanwhile, multiple House representatives and Senators are calling out to President Biden to make a move as well. In a High Times exclusive interview, New York Senator Kristen Gillibrand called for an end to prohibition. “Studies show that legalizing marijuana could help reduce violence in international drug trafficking and generate billions of dollars for the economy,” Gillibrand said. “The vast majority of Americans agree that marijuana should be legalized—that’s why I’m calling on the Attorney General and the Drug Enforcement Administration to swiftly deschedule marijuana from the Controlled Substances Act.” Many predict that rescheduling cannabis could give Biden a huge boost in the upcoming election later this year. A survey conducted by Lake Research Partner showed that Biden could benefit from an 11% boost from younger voters (based on the opinions of 900 voters used in the survey, spread out across the U.S.).

https://hightimes.com/

Yet Another Study Shows Ketamine To Be An Effective Treatment For Depression

Ketamine may be an effective treatment for severe depression, according to the results of a recently published clinical trial. The research, which was published in the peer-reviewed Journal of Affective Disorders, found that participants with major depressive disorder showed a significant improvement in symptoms including suicidality after receiving intravenous ketamine infusion therapy. Major depressive disorder, also called clinical depression, is a mental health disorder characterized by persistent feelings of sadness and a loss of interest, according to information from the Mayo Clinic. The condition affects about 5% of the adult population globally, according to data from the World Health Organization, and can lead to difficulties in all aspects of life including home, work and school.  Depression is often treated with antidepressants and mood stabilizers, but these treatments have shown only limited success. Some patients do not respond to these options at all, while many others fail to achieve remission.  In prior studies, ketamine, which is commonly used as a dissociative anesthetic, has shown promise as a treatment for depression in patients who have not shown improvement with other therapies. The drug’s effects are particularly rapid and have shown the potential to reduce suicidal ideation in subjects with major depressive disorder. The new research was conducted at four leading medical institutions across the United States as part of a larger study to determine blood-based biomarkers of depression treatment response. While the effects of ketamine can be dramatic, it is not well understood who can benefit the most from the drug. With the study, researchers hope to identify blood-based biomarkers to help predict who will benefit the most from ketamine therapy. “The main purpose of the study is to find a blood test that can help predict who will benefit from intravenous ketamine,” study author Sagar V. Parikh, a professor of psychiatry at the University of Michigan, explained to PsyPost. “This first publication looked at whether three infusions were capable of causing remission (it was in 52% of people in less than two weeks, which is wonderful news). We believe that ketamine will be a standard and highly effective treatment for people who don’t respond to traditional antidepressants.” The study was conducted between May 2017 and March 2020 and involved participants from the Mayo Clinic, the University of Michigan, Johns Hopkins University and Pine Rest Christian Mental Health Services in Michigan. To qualify for the study, prospective participants were required to be between the ages of 18 and 65 years old and diagnosed with major depressive disorder or bipolar I or II disorder. Participants also were required to have a history of treatment resistance to traditional antidepressant therapies. Participants who were selected for the research continued taking their existing medications throughout the trial. Researchers monitored the participants using diagnostic tests to assess factors such as depressive symptoms and suicidal ideation. The study participants received a total of three ketamine infusions over 11 days. Each infusion was administered over 40 to 100 minutes, depending on individual responses and concerns for potential side effects. Researchers closely monitored cardiac activity and side effects during treatment. About half (52%) of study participants achieved remission as determined by a marked reduction in their scores on the diagnostic tests. Researchers noted that the rate of remission was significant given the participants’ history of treatment resistance. Participants also showed a marked reduction in suicidal ideation. At the onset of the study, 81% of participants had notable suicidal ideation. Following the ketamine treatment, two-thirds of participants showed a reduction in suicidality of at least 50% as measured by the diagnostic tools. “There is great hope that ketamine is a new and highly effective treatment, and that it might be possible to find a blood test to tell us if ketamine is the right choice for a particular person,” said Parikh. The long-term objective of this line of research is “to find fast and effective treatments for depression, so people don’t have to wait months and use trial and error to find the right treatment.” During or after the infusion treatments, some participants experienced notable side effects, which were monitored using the Ketamine Side Effects Scale. Most side effects, however, had largely subsided after 60 minutes. Researchers recorded only one serious adverse event, an episode of hypoglycemia in a participant with diabetes. “The treatments were extremely well tolerated,” Parikh said. “We also tried to see if even slower infusion would make it more tolerable, and if the speed of infusion (slow at over 100 minutes versus standard over 40 minutes), and found that slower did not have any advantages.” The researchers noted the limitations of the study, including the lack of a control group that would have allowed for comparison to a placebo or alternative treatment. “These are the clinical findings, we are still waiting to publish our reports on various biomarkers found in the blood,” Parikh explained. “Those findings will come out over the next year.”

https://hightimes.com/

Drug Testing Access at Australian Festivals May Have Prevented Past Deaths

It’s already fairly well known that music festivals tend to come with plenty of illicit drug use. The activity is so common at festivals, and in dance scenes as a whole, that organizers and attendees alike are becoming increasingly more equipped to combat potential overdoses through a variety of measures. A new study published in the International Journal of Drug Policy underscores the impact of these harm reduction strategies and consciously incorporating them into events, looking at the amount of drug-related deaths at Australian music festivals, the common trends and what may have helped to prevent them. Moreover, the researchers ultimately confirmed that mobile medical care, drug testing and increased consumer education and awareness could have prevented these largely unintentional deaths. Researchers note the high prevalence of drug use among festival attendees compared to the general population, citing a study finding that 44% of over 5,200 surveyed Australian music festival attendees reported past-month use of illicit drugs. That said, it’s no surprise that more instances of drug use often result in increased cases of drug-related harm. To examine the prevalence of drug-related deaths at Australian music festivals, researchers conducted a descriptive case series study using the National Coronial Information System (NCIS) looking at relevant data between July 2000 and December 2019. The study noted a total of 64 deaths, predominantly males (73.4%) aged in their mid-20s (ranging 15-50 years old). MDMA and alcohol were the most common substances across the study period, reported respectively in 42 (65.6%) and 30 (46.9%) cases and with alcohol co-detected with MDMA in 14 (33.3%) cases.  Deaths were primarily associated with toxicity from MDMA and other stimulants (19 cases), toxicity from other drugs or drug combinations (11 cases) and either natural causes (10 cases) or external injuries (24 cases) in the setting of drug use, like those involving motor vehicle or train collisions or a passenger or driver using drugs. The majority of cases involved unintended harm, with 11 deaths (17.2%) related to intentional self-harm. So, what exactly are the ways to prevent a drug overdose at these events? Authors note that there is limited evidence surrounding the efficacy of specific law enforcement-related approaches. While drug detection dogs have been utilized in Australian festivals for more than two decades, researchers note some research showing this can actually increase risk of drug-related harm. They also mention that this method may “paradoxically increase the risk of overdose,” with attendees potentially leading to festival goers hiding drugs internally or quickly consuming drugs to avoid arrest. There’s drug checking and testing, which allows members of the public to analyze drugs to confirm if they contain any potentially dangerous or unexpected substances and how much of a substance is actually in a given powder, pill, tablet and so on.  Researchers note the body of research finding that this option indeed demonstrates a reduction in drug use and related harm. Combating the notion that people may be more inclined to use drugs with the ability to test them, researchers cite a recent study finding that festival attendees are no more likely to use drugs at festivals whether drug testing is provided or not. Music festivals also tend to have mobile paramedics, peer harm reduction workers, chill-out spaces and may even incorporate specific physical design elements to reduce the risk of drug-related harm. Authors note that in these 64 cases, the most common cause of death was MDMA toxicity. While there are a variety of factors associated with increased risk of adverse effects surrounding MDMA usage, researchers highlight the variability in dose amounts as a key factor. For this study, the average MDMA concentration among the deaths was above a range usually associated with toxicity, showing an opportunity for harm reduction by drug checking and testing. “Drug checking is not merely an analytical process; counsellors are available on-site to discuss analytical results and provide important harm reduction interventions,” researchers write. “This approach is favoured by festival patrons and has resulted in positive outcomes including changing dosing patterns, trust of health providers, and increased drug harm reduction knowledge.” However these services are still in their infancy in Australia, despite being available throughout Europe and North America for a number of decades. “Harm reduction strategies such as roving first aid volunteers, mobile medical care, spaces to rest, hydration stations, and drug checking services, may best address some of the risks associated with illicit drug use at festivals, in addition to increased consumer education and awareness,” authors conclude. “It is important to understand the factors involved in these incidents in order to inform policies around harm reduction and law enforcement at music festivals in future to prevent further deaths.” In an interview with online music magazine and community platform Resident Advisor, co-author Dr. Jennifer Schumann underscored the findings around harm reduction, citing that two in three Austalians support drug checking services along with recommendations from coroners throughout the region to implement these services. “It’s possible that information about the drugs these people were taking, along with harm-reduction advice from drug-checking service counsellors, may have prevented death in some cases in our study,” Schumann said. It’s a particularly relevant topic Down Under, with renewed calls for more safety measures after nine people were hospitalized in January from suspected MDMA overdoses at Melbourne’s Hardmission Festival.

https://hightimes.com/

The Best Ingredient

During any given week, chef Nate Santana, winner of the first episode of Netflix’s Cooked With Cannabis, pushes himself to concoct several new dishes in order to keep things raw and fresh. His dishes are inspired by the hallmarks of Southern hospitality and many other cultural influences. The Palmdale, California native crept up the ladder of professional culinary arts, eventually moving to Los Angeles. He began cooking at Culver City’s award-winning restaurant The Wallace while still a student at The Art Institute of California. At the time it was run by chef Joel Miller, one of his mentors in the art of food. Santana climbed the ranks at The Wallace to executive sous chef and ended up curating the menu there himself. Armed with experience, Santana became the chef de cuisine at New Orleans-themed Preux & Proper—following the lead of chef Sammy Monsour. For those out of the know, Preux & Proper was a Michelin-rated fine restaurant that honed in on the heritage of the South through elements of hospitality, seasonality, sustainability, and craft-level cocktails. It was one of many restaurants, however, that did not survive the pandemic. Santana is currently sous chef at The h.wood Group, where he curates the food for private events, and owner of Dorthy’s Pizza, a private pop-up collective of gourmet pizza delicacies he launched with acclaimed chef Jack Hotchkin. And when I say pizza, I mean pizza with ingredients like boar sausage, Spanish chorizo, balsamic redux, fennel pollen, Fresno pepper jelly and so on—food that you can taste hours later, which is a stoner’s dream. Cannabis is at the core of Santana’s cooking mentality. When cannabis is involved, however, due to legal restraints, the infused dishes are usually served at private events in the form of a pop-up. Fortunately, pop-ups in Los Angeles and New York cater to the high bar set by foodies, as does Santana. A few years ago, before the pandemic, I was blessed to attend two such pop-ups, including an infused private, underground pop-up experience called Cultured, Create + Destroy in the Venice Beach area of Los Angeles, with an exclusive shortlist of cannabis-adjacent journalists and influencers. A large fan leaf adorned my plate at my place sitting, and each guest received a live resin vape pen. The food was infused with locally sourced pot from Los Angeles-based Botafarm Genetics. Botafarm was founded by Jay R., the grandson of a winemaker from Bordeaux, France, and Santana is their go-to chef. My particular menu for the evening included a multi-layered experience including Kumamoto oyster, Botafarm-infused fermented hot sauce—and Jack Herer-derived terpene for the kicker. One of the other choices for the main course was pork loin al pastor, with charred tomatillo pesto, with Botafarm blueberry muffin with a dehydrated pineapple chip. “I think LA is ahead of its time in terms of cuisine,” Santana tells High Times. “The food is really good. There’s just so much culture here. There are a lot of really good chefs here that are pushing the boundaries. I think all of the diversity and culture is good for LA. You could say the same thing about New York.” Santana’s food has a multi-layered taste you can’t exactly describe in words, enhanced by terpenes and the natural herbal taste of cannabis. On Instagram, Santana calls cannabis “the world’s best ingredient.” “I mean, it just is,” Santana says. “Everyone knows it can improve your health, lower stress, improve stimulation. It’s an ingredient I’ll keep using all of my life. It does the same thing for food: the flavors are great. If you can do it right, it can do really good things for food. I personally like the appearance and you can taste the flavor, at least when it’s sourced from really good farms.” He explained that cannabis’s herbal flavor is more useful than common herbs like rosemary or thyme. Cannabis has its own pleasurable taste. “It’s just like smoking, you can really taste the difference when it’s good quality.” Santana explained how he uses the same process to select cannabis that he does when sourcing vegetables locally, from farmer’s markets and other places that have farm-to-table quality foods. Sometimes he wants his guests to taste the weed and sometimes he doesn’t. “It really depends,” he says. “Like any great product, if it’s grown by farmers and tastes great, you really want to highlight that.” Santana won the first episode of Cooked With Cannabis on Netflix, which became available on the streaming service back in 2020, by playing it safe with a grilled burger, which the judges loved. In every episode, there’s a $10,000 dollar prize. (Chef Manuel Mendoza was the final winner of the season.) The chefs were judged by singer-songwriter Kelis and food expert Leather Storrs, joined by Ricki Lake, Mary Lynn Rajskub, singer Elle King, and comedian Jo Koy, and the first episode had a backyard grill theme, which Santana nailed. His professional achievements peaked only to have his world thrown upside-down by the pandemic, as in-person pop-ups were core to his overall persona. “I was on the first episode of the first season,” Santana says. “And I filmed that back in 2019. It’s weird how it seems so far away now. And then in April 2020, everything just got shut down. So it’s a competition show. It was three courses and we had to do infusions, freezer foods, how to do the right dosage. It was fun and I’d do it again.” When the pandemic wreaked havoc on his in-person private pop-up plans, he pivoted to other ventures, including Dorthy’s Pizza, a gourmet pizza pop-up collective, named after his grandmother. Dorthy’s Pizza deep dish cheesy crusts are a wonder to behold, and are cooked with the secrets only Santana knows. Follow and book Santana by visiting his Instagram at @chef_nate_santana and @dorthys_pizza for a “little slice of society.” Recipe by Chef Nate Santana 100 grams of mint 30 grams cilantro 50 grams parsley 2 Fresno peppers 1 shallot 2 tsp lemon zest and juice each 3 tsp Sherry vinegar Salt to taste Pepper to taste Olive oil—enough to bring together 3 tbsp Pot d’Huile infused olive oil Instructions This article was originally published in the December 2023 issue of High Times Magazine.

https://hightimes.com/

Back in the Game

Yelawolf is back in Nashville, Tennessee not long after performing a sold-out show with rapper-turned-country star Jelly Roll in Denver, Colorado. Wolf’s explosive set was a lesson in how all artists should command a stage—he was energetic, engaging, and a little bit enigmatic. Wearing a pair of aviator sunglasses, a black beret, and a leather jacket, the Alabama-born artist doesn’t look like the average MC. The tattoos, leather cuts, and patches make him look more like a Hell’s Angel than a former Shady Records signee. But that’s partly what makes Yelawolf so intriguing. Not to mention his musical versatility is almost otherworldly. Born Michael Wayne Atha in a small town in Alabama, Yelawolf jumped around as a kid but spent the bulk of his childhood in Antioch, Tennessee. He naturally gravitated toward the rebelliousness of skateboarding, punk rock, rock, and hip-hop, which inadvertently shaped Wolf’s future. His entire catalog is an amalgamation of those influences—from 2008’s Stereo: A Hip Hop Tribute to Classic Rock and 2015’s Love Story to 2019’s Trunk Muzik III and his more recent project with Shooter Jennings, 2022’s Sometimes Y. Translated live, it’s clear he was born for the stage. “I’ve never had stage fright,” he tells High Times. “But I was definitely raised around a different type of live performance. I grew up going to underground hip-hop and punk rock shows in Atlanta. My first gangster rap show was Three 6 Mafia and Mystikal, and that was rowdy. I like rowdy. So when we first started doing shows in Atlanta, we had kids that would wear helmets to our shows; it was that crazy. We just kind of made it our thing, at least I did—head-banging, crowd surfing. Then I applied that energy to hip-hop because when I saw Method Man and Redman when I was a kid, I crowd surfed in the pit. Or Beastie Boys, you know.” Armed with that same ethos, Michael Wayne Atha was transformed into Yelawolf in his late teens. His first show was at the 231 Club in Jackson, Alabama, although it was more of an appearance. He shared the stage with 10 other guys and only got to spit a few bars, but that’s where the journey began. For some, the mere thought of performing in front of a crowd is terrifying, but Yelawolf never struggled with that. “I was kind of born with this fearlessness,” he says. “I got on stage when I was 5 years old and sang with my uncle. He held me up to the mic. And my mom raised me around artists. She was dating dudes who were on the road, so being on stage and around buses and artists was kind of normal. But ego supersedes talent. It’ll train you to get better if you just have the balls to go up there and be persistent. Falling down in front of people—I think that’s the key—like literally falling off stage or forgetting a verse or just plain getting booed.” Getting booed isn’t something Yelawolf experiences these days. If anything, his audience is salivating for more by the time his set is over. But for him, it’s off to the next thing, the next city, the next show. Wolf’s punk rock ethos has remained intact since he was a young wolf pup, but the “sex, drugs, and rock ‘n’ roll” lifestyle that so often comes along with a career in music can become cumbersome. Yelawolf has certainly weathered some storms, but he always seems to land on his feet. However, his experiences with drugs and alcohol have altered the way he moves. Although he has the utmost respect for the medicinal benefits cannabis can provide, he can no longer use it. It was only four years ago when he was involuntarily put on a 72-hour psychiatric hold in San Diego or, what he called, “5150’ed.” “They sent me to a padded room and shit, for real,” he remembers. “It was like that Green Day video [‘Basket Case’]. They kept me in there for three days and then I had to go to rehab for a while. I love weed. I wish I could smoke it. I love the smell of it and I love the idea of it, but the therapist I was talking to said I was basically clinically allergic. They said I could smoke a bunch of different strains, but by the time I found one that may or may not fit me, I would be back in the same situation.” Experiencing such a traumatic incident would scare anyone into sobriety—at least for a while. Yelawolf has periods where he doesn’t use anything, but then he’ll drink whiskey or other types of alcohol. But to him, that’s much more manageable.  “You just gotta know yourself,” he says. “You have to really fucking trust your gut. Shit does not affect everybody the same, and that’s a fact. Getting to know yourself…I wouldn’t suggest anybody leaning on medication for what could be a mental health or spiritual health issue that you just need to go figure some shit out by yourself. So that’s what I did. Drinking is something I can measure. I can measure my buzz. I can follow it, and I can take it as far as I want to or not. It’s safer for me than the alternative.” Yelawolf is currently focused on releasing his next rap record, a double album and 180-degree pivot from the project he did with Shooter Jennings. A couple of factors contributed to his decision to jump back in. “After the rock ‘n’ roll record with Shooter, it was so bittersweet to have such, what we considered, a really amazing project with critical acclaim and shit,” he says. “But it was also becoming like a paperweight for me. We had to remove something that was holding it down, but we couldn’t put our finger on it. It became one thing after another. We couldn’t do a show because Shooter isn’t available, or this guy’s doing this or that guy is doing that. I didn’t want to get another band because I already branded them. “That kind of pushed me into doing another record. The other part was like a creative voice. I was itching for hip-hop badly again and frankly, I was inspired, like Kendrick Lamar is doing amazing work right now. I was also inspired by the wack shit. I’m not gonna say names, but I was inspired by the garbage that was coming out. And I was like, ‘Man, I want to put my foot back in the game.’ Then, of course, there were the people who said, ‘Oh, he quit rapping.’ I never said that.” With his hunger for rap at a ravenous level again, Yelawolf hit up his longtime collaborator James Ryan Ho, better known as Grammy Award-winning producer Malay, and fellow producer WLPWR to get to work. But rather than doing one project, Wolf did one with each producer, hence the double LP. “I went and did an album with WLPWR, and I went and did a record with Malay. They were different but vibe wise, they were just so good. We wanted to put them out as a double album instead of stretching it out and dangling the carrot so to speak. We came up with the title War Story because it’s opposite of Love Story.” Yelawolf hasn’t set a release date yet, but the project will live under the Slumerican umbrella. “The album I did with WLPWR is called Trunk Musik Forever and then the other album is called Michael Wayne that I did with Malay, but they’ll be under one package. Michael Wayne is the most honest I’ve ever been. Trunk Musik Forever has some really personal shit, but it’s not a downer. It’s got some really fun records.” This article was originally published in the December 2023 issue of High Times Magazine.

https://hightimes.com/

The Other Kind of Drug Test

There’s a longstanding and popular belief amongst our community that you can’t trust anyone who doesn’t get high. That a person in the circle who passes on the joint is an automatic flag on the field and a fifteen-yard penalty. Regardless of if you’re part of the industry, the community, or just a casual consumer, it’s an easy idea to understand. Hell, we’ve all seen Gordon Ramsay lambasting a chef for not tasting their food and it’s tough to imagine buying steaks from a butcher who passes up BBQ. Not to mention that, in the cannabis world, we put a lot of stock behind how well a person holds their smoke. However, what used to represent a sort of marijuana-mason’s handshake has over the years become a method of assuming a person’s passion for the plant or their craft. We hold a degree of scrutiny over those at the party who pass on a puff. So what about if someone used to partake but stops for personal or health related reasons? Should they experience the same scrutiny? Do they experience a loss in relationship with the plant? Does their work suddenly become less authentic? I mean, to give the other half of the chef argument from earlier, plenty of cooks taste the soup and still have it come out tasting like Campbell’s. We respect a person passing the pipe for a tolerance break, but there’s a different kind of feeling when someone lets that break stray into a hiatus. I don’t want to say that it’s easier to take a break as a casual consumer, but that taking one when you’re living in the deep end of the pool draws attention from the other swimmers, and never the good kind.  What I’ve started to realize is that this reflexive litmus test we keep giving each other now disregards a basic concern for each other’s well-being. There are a lot of personal and health-related reasons a person might want to take a break from weed but still enjoy the fellowship of community. I mean, let’s face it, this weed game is like underwater living: there’s always an element of pressure surrounding you and it will fill all the available space if you let it. This pressure contributes to keeping up a status quo instead of stopping to address issues that can have a huge effect on our lives. I’ve had a lot of friends over the years who’ve admitted to me that they’re not smoking but don’t want to tell people so it doesn’t become a thing. Lately, I’ve seen more of a rise in people needing to take a break from smoking to work on themselves and this leading to them exploring other connections to weed while focusing on their own health. The whole thing got me questioning if we aren’t being a little quick to judge and if, like so many things related to this plant, this correlation between smoking and inclusion is no longer so cut-and-dry (no pun intended).  Much of this preconception seems rooted in that old-school “are they a cop” mentality—the idea that, for starters, we need to see you get high in order to know you’re one of us. When the green rush spread over California, we used this litmus test to help identify individuals who were only hanging around for the money. Drinkers and non-drinkers alike will tell you they feel like a sore thumb when they’re at a bar without a glass. So anyone who wouldn’t hit the joint or didn’t know how to hold one was seen as a cash-grabbing outsider, (though it didn’t really prevent them from collecting the checks). I think most of us can agree we’ve long used smoking as a way to break the ice but much in the same way the business world treats booze, the industry and the scene too often takes how many dabs a person takes, or blunts they smoke as a reading of acumen instead of a reflection of their tolerance. I guess what I’m saying is, when someone says they don’t smoke, we might want to respectfully ask why instead of inquiring if the DMV had to list baby lungs on their driver’s license. If you’re unsure as to if by not smoking someone is severing a connection to the source, you have only to look at Bask Triangle Farms in Spain, whose owner told me how, after seventeen years of smoking weed, he was suddenly faced with serious health issues and some even more difficult choices. Doctors told him that despite multiple surgeries on his lungs he could no longer smoke cannabis. The pill was a tough one to swallow for a person who’s been growing and smoking since they were in high school. Despite this, he’s kept a thriving connection to his work and his brand has gone on to dazzle judges at Europe’s Spannabis Champions Cup, Seville Cannabis Cup and Secret Cup Bizkaia. When I asked him if he felt quitting smoking had taken anything away from his growing or breeding, he said, “there is no one exclusive way to test the work of a breeder and hashmaker.” He described how, over time he’s developed other ways to connect to the plant, through edibles and even low-temp dabs and that none of it has severed his joy for the work. The journey has shown him that the inherent risks involved in smoking weed aren’t part of his connection to cannabis. When asked if doing away with joints and bongs has caused him to miss the next big strain in his R&D room he said absolutely not. While he personally sees maintaining some kind of weed in your system integral to staying on your game, as he put it, “there are many ways to understand, connect with, or use cannabis.” Looking at the list of multiple award-winning in-house crosses, I’d say he has a point. Another example is The Real Cannabis Chris, a California grower and hashmaker who took a step back from smoking for over three years to work on his relationship with himself and others. After years of smoking and dabbing, he developed a social anxiety that made it difficult to connect with strangers and even loved ones. Chris talked about how, after making the difficult choice to focus on mental health, what started as a tolerance break grew into almost a year and that’s when he discovered that all energy he had been putting into smoking transferred into growing, both as a person and better plants. “I was more present in my life, in my relationships and in my garden and this led to asking more questions and looking for more answers.” This is how he developed the next phase of his connection to the plant. As more time passed, he began to notice all these new smells in the buds and in the jars. This evolved connection to his plants, combined with the one he shares with the team who help grow and taste the work, is what he attributes to creating a kitchen that has now won a slew of first prize wins, judge’s picks, and a chance to travel to Thailand to compete with players from around the world. Arguably one of the most awarded hashmakers of 2023, he points out that it wasn’t until well into this sabbatical that he began winning multiple accolades for his work. When it comes to judging someone by their craft, well that’s the easy part. Things move awfully fast around here and if a person’s work doesn’t hold up, the community will absolutely let you know. When asked if they’ve received criticism from comrades or contemporaries for passing on the joint, Chris commented, “at first glance it’s easy to throw shade without an understanding. People might think I’m just in it for the money but what they don’t know is that I’ve been at this since i was basically a kid.” He mentioned how after a podcast joked that he hadn’t smoked in a decade, he received a ton of comments that were almost attacking his credibility. The situation prompted him to film a video discussing his three-and-a-half year break relating to a journey of mental health and the comments transformed into an overwhelming amount of responses from people who were thinking about taking their own break but wanted to know how he maintained his connection to the plant and the people while not puffing. Bask Triangle echoed a similar sentiment, “In this industry there is always someone who wants to speak badly about others and will use any reason to do so. But we should not waste time on such trifles and we must continue doing what each person likes the most, without paying attention to what others say.”  These are just two examples of how an individual can take a break or stop smoking altogether and discover new connections that enhance and compliment their work with cannabis while also focusing on something we take for granted: health. It’s something that we should really give more space to, and if that leads you to a different place in your cannabis journey, I’ll still welcome you around the water cooler. I think we’ll probably always have a hiccup with people who are in the room but don’t have a connection to growing, tending, or consuming cannabis but if you want to know if a person choosing to go off the sauce matters, maybe ask them the follow-up of how they’re doing. I’ve learned a lot about not making split judgements on someone choosing not to smoke or to take a break and that surviving alongside this plant and the mileage this life puts on the car often runs deeper than what you see out at the session. As far as judging a person by how much of their jar they smoke when they sit down, why not see how much of it you smoke instead.

https://hightimes.com/

The Beatles’ Psychedelic Painting ‘Images of a Woman’ Auctions for Over $1.7M at Christie’s

In 1966, all four members of The Beatles painted a piece in oil and watercolor on Japanese paper, “Images of a Woman,” at the peak of their fame while on tour in Japan. The piece went up for auction Feb. 1 at Christie’s New York in New York City, and sold to a buyer with astounding results, for over $1.7 million, after a lively bidding round. The high-end auction features lavish, upscale art dating back centuries. The Beatles classic lineup—John Lennon, Paul McCartney, George Harrison, and Ringo Starr—all painted a quarter of the piece and signed the painting. Bidding for “Images of a Woman,” 54 cm x 78 cm, began at $400,000-600,000, and the final price the buyer will have to pay is $1,744,000. It’s likely the only painting with work contributed by all four band members. Christie’s posted a 12-photo gallery showing the Fab Four painting it. The latest event at Christie’s New York is a rock ‘n’ roll collector’s dream: “The Exceptional Sale,” also features priceless art and memorabilia like a gold-colored crocheted vest that was worn by Janis Joplin (bidding started at $50,000), and Elvis Presley’s 1965 guitar made by The Fred Gretsch Manufacturing Company, used during his 1969 Las Vegas, Nevada residency (bidding started at $350,000). David Gahr photographed Joplin wearing the vest on the roof garden of the Chelsea Hotel in 1970. Joplin’s vest eventually ended on the cover of the November 1976 issue of Rolling Stone and was one of her favorites pieces to wear. High Times learned that bidding for The Beatles painting on Thursday got intense, with about three in the room holding out to the end, among many other bidders that called in. Organizers were pleased with the overall results. “It was great to see The Beatles topping the charts again with this amazing auction result,” The Head of Christie’s Exceptional Sale, Casey Rogers, told High Times. “There’s nothing like this painting. It’s a work of art. It’s a piece of memorabilia. We told that story, and the market responded with strong competition from bidders in the room and on the phone.” Keep in mind that The Beatles—defunct for over 50 years—topped the charts months ago in November 2023 with “Now and Then,” a song they finished using a little help from AI. The event was designed only for serious collectors with money. “The Exceptional Sale” featured everything from an elegant 18th century candelabra to a Wedgwood & Bentley sculpture of the infant Hercules in black basalt. Other notable items date back further. The French and English furniture masterpieces include a pair of tabourets belonging to Empress Joséphine de Beauharnais, and a Louis XIV Gobelins tapestry formerly in the collection of William K. Vanderbilt (1849-1920). Psychedelics and cannabis have a well-known impact on the music (and art) of The Beatles. Lennon and Harrison, along with their wives, were the first to take LSD in 1965, after being dosed by a dentist. They would become part of the profound impact psychedelics had on Western counterculture and music. This painting shows how psychedelics impacted their art. The four painted “Images of a Woman” just two months after recording Revolver, perhaps one of their most psychedelic, and most respected albums, taking a 180-degree detour from their early pop era that was based on radio-friendly love songs. At the time when “Images of a Woman” was painted in 1966, “Beatlemania” was at its peak. The moment the Fab Four stepped off their plane at Haneda Airport in Tokyo, Japan on June 29, 1966, The Beatles used a “moment of calm at a tumultuous time,” to create a piece of abstract art with some of the countless art supplies fans had given them. While Beatlemania was strong in Japan, so was the politically nationalist Japanese, who saw The Beatles as “emblems of an invasive Western culture,” and completely rejected them, and the band was confined for most of their five-day tour in Japan to the presidential suite at Tokyo’s Hilton Hotel. They received death threats from Japanese who rejected Western culture and considered the band to be a representation of that. “I’ve never seen so many people guarding us,” drummer Ringo Starr said at the time. They took a piece of Japanese watercolor paper and put it on a table, then placed a ceramic lamp in the center, where they would sign their names. Lennon in particular was interested in art. In 1957, young Lennon attended the Liverpool College of Art where he met former Beatle Stuart Sutcliffe. He continued to dabble in art his whole life. High Times reported on another Beatles-related art piece that has a connection with cannabis. Antiques Roadshow season 46, episode 2, featured a cartoon depicting McCartney being searched for pot by airport customs and with an autograph from the singer. Christie’s is an auction house founded in 1766 by James Christie. The piece sold at Christie’s New York is probably the most valuable visual art the band has created. 

https://hightimes.com/

Texas Attorney General Sues 5 Cities Over Weed Decriminalization

Texas Attorney General Ken Paxton on Wednesday filed lawsuits against five cities that have passed marijuana decriminalization measures. The legal action was filed against the cities of Austin, San Marcos, Killeen, Elgin, and Denton “for adopting amnesty and non-prosecution policies that violate Texas laws concerning marijuana possession and distribution,” according to the attorney general’s office. In 2022, the five cities each adopted ordinances or civic policies that instruct police officers not to enforce state laws prohibiting the possession or distribution of cannabis. After filing the lawsuits this week, Paxton said that such policies are prohibited by the Texas Local Government Code, which bars municipal and county governments from adopting “a policy under which the entity will not fully enforce laws relating to drugs.” “I will not stand idly by as cities run by pro-crime extremists deliberately violate Texas law and promote the use of illicit drugs that harm our communities,” Paxton said in a statement on Wednesday. “This unconstitutional action by municipalities demonstrates why Texas must have a law to ‘follow the law.’ It’s quite simple: the legislature passes every law after a full debate on the issues, and we don’t allow cities the ability to create anarchy by picking and choosing the laws they enforce.” The attorney general also noted that under Article 9, Section 5 of the Texas Constitution, it is illegal for municipalities to adopt ordinances that are not consistent with the laws enacted by the Texas Legislature. With the lawsuit, Paxton has asked the district court to overturn the city ordinances and instruct local officials to enforce state law. Julie Oliver, executive director for Ground Game Texas, a group that works to advance progressive issues including local marijuana decriminalization ballot measures, said that the attorney general’s legal action seeks to undermine the right of Texans to govern themselves at the local level. “Ken Paxton’s lawsuits represent an anti-democratic assault on the constitutional authority of Texas Home Rule cities to set local law enforcement priorities,” Oliver told local media. “In each of the cities sued, a supermajority of voters adopted a policy to deprioritize marijuana enforcement in order to reduce racially biased law enforcement outcomes and save scarce public resources for higher priority public safety needs.” In Denton, a city of about 140,000 people in the Dallas-Fort Worth metropolitan area, voters passed an initiative to decriminalize misdemeanor marijuana offenses in November 2022. The ballot measure received the approval of more than 32,000 votes and the election marked the highest voter turnout recorded in the city’s history. “This ordinance has now received more votes than any council member or mayor in the history of Denton,” Nick Stevens from Decriminalize Denton, a grassroots organization behind the ordinance, told the Denton Record-Chronicle after the election in 2022. “We’re ecstatic that Republicans, Democrats and independents came together to reclaim their power in the city.” Denton’s marijuana decriminalization policy, however, has not yet been fully implemented and the city’s police have still been issuing citations for misdemeanor marijuana offenses. In June, the Denton City Council considered an ordinance that advocates said would have strengthened the measure approved by voters but voted 4-3 against the proposal. The attorney general’s lawsuit is partly based on HB 2127, a bill passed last year that restricts so-called home rule authority. Attorneys for cities including Denton, San Antonio, Waco and Plano that filed suit against the law last year explained that home rule allows local governments “to create policies that address local concerns that vary from jurisdiction to jurisdiction based on many factors such as demographics, population density, environmental concerns and public safety issues.” But Stevens said that HB 2127 does not cover the city marijuana decriminalization measures because it states that it only applies to municipal or county codes involving agriculture, finance, insurance, labor, natural resources and occupations. “Ken Paxton should read this law before wasting Texans’ tax dollars with another frivolous lawsuit that distracts from the work we have done to deliver for the people of Denton,” Stevens said. Ground Game Texas is currently sponsoring a campaign to decriminalize marijuana in Dallas. Known as the Dallas Freedom Act, the measure would end most arrests and citations for Class A and Class B misdemeanor marijuana possession. The proposed ordinance, which is similar to the one passed in Denton, would also require city leaders to report on cannabis enforcement and forbid the use of city funds for laboratory testing to distinguish hemp from marijuana. “The Dallas Freedom Act is a dynamic initiative that will reduce unnecessary arrests, address racial disparities in marijuana enforcement, and save millions of dollars in city and county resources for much-needed public safety programs,” Tristeza Ordex, campaign manager of Ground Game Texas, said in a statement about the proposal.

https://hightimes.com/

Ireland Government Approves a Nine-Month Delay on Cannabis Legalization Vote

The Irish government has delayed on discussing a bill that would legalize cannabis possession for nine months. A report submitted by the Citizens’ Assembly on Drugs Use completed its review of Ireland’s current drug policies in October 2023, and released a final report on Jan. 25, which includes 36 recommendations for prioritizing marginalized groups and communities, focusing on prevention and recovery, and more. On Jan. 24, 2024, one day prior to the release of the report, Taoiseach (TD) Leo Varadkar (who holds a position similar to that of a prime minister) attended a Dáil Éireann parliament hearing and joined legislators in discussing the path forward. “The chairperson of the Citizens’ Assembly stated there is no time to waste. No time to waste, taoiseach. If it saves one life, literally one person, if that can save one life, then it’s worth changing course in relation to criminalizing people,” said Gino Kelly, a TD for the People Before Profit political party, said in the hearing on Jan. 24. “So my question is: will the government take the recommendations—and now [not only] take the recommendations in relation to policy? But the key thing in relation to that report was legislative change. We have [had] the misuse of drugs act since [the] 1970s, criminalizing people, sending people into the criminal justice system, sending people to the courts, jailing people…It doesn’t work, taoiseach.” Kelly continued that the country’s prohibition has “stigmatized, marginalized and criminalized not only individuals, but communities across the country.” He added that if the government decided to accept the commission’s report, that “we can change the course, and we can actually save lives and take people out of the criminal justice system.” Varadkar responded, stating that decriminalization should come with other policies as well, and that multiple committees should help manage cannabis reform. “We shouldn’t just try to copy models in other countries,” he added. On Jan. 30, Varadkar proposed to delay the cannabis bill vote by nine months, which would halt progress until at least October. He also called for the creation of a special committee. “One of the things the special committee will have to tease out is what does decriminalization really mean in a legal context—under an Irish context?” said Varadkar. “Does that mean that’s not an offense at all? Doesn’t [that] mean that it’s not an indictable offense? Does [it] mean that it’s an offense without a penalty? Is there something like penalty points? Or does it actually mean that, up to a certain amount of each particular substance, that would not be illegal?” “In my view, drug use and misuse by individuals should be seen primarily as a public health issue and not a criminal justice matter,” Varadkar continued. “I certainly think that shaming people and blaming people and criminalizing people isn’t an effective policy.” Other legislators in support of ending prohibition and moving Ireland forward in drug reform are disappointed in the delay. “The government has announced they will try to delay our Bill to decriminalize possession of small amounts of cannabis by nine months,” said TD Paul Murphy on X. “That is simply an attempt to kick the can down the road. They talk about a health led approach to drugs. Now it’s time to walk the walk. On Jan. 31, the government approved the nine-month delay. “Passing this bill today would have allowed it to go to the committee stage where we could have had this conversation and actually started taking meaningful first steps towards realizing the recommendations of the citizens assembly,” Kelly said on X. “Instead the government chose to do nothing.” The bill was introduced in November 2022 by Kenny, Murphy, Mick Barry, Brid Smith, and Richard Boyd Barret. On an illustrated line of progress on the Ireland bill page, the Misuse of Drugs (Cannabis Regulation) Bill 2022 is only on step 2 of 11. Next it must be discussed by legislators to reach the Committee Stage, Report Stage, and Final Stage in Dáil Éireann parliament, which must also be discussed in the upper house, called the Seanad Éireann, as well. The Citizens’ Assembly on Drugs Use is made up of 100 people in total—99 general public representatives and one independent chairperson—who are selected at random. In 2023, the assembly spent five previous meetings listening to both experts and first-hand accounts from people suffering from addiction. In October 2023, the assembly voted on recommendations to send to legislators—39 chose to vote for approaching drug policy from a public health standpoint, while 38 voted to implement legalization and regulation of cannabis. Had the latter received one more vote, the assembly would have instead recommended legalization. “This indicates an appetite to completely overhaul the State’s cannabis policy, including full legislative decriminalization [sic], regulatory implementation around sale and supply alongside the repeal of prior criminal convictions for cannabis use,” the assembly announced in a statement at the time. Medical cannabis has been legal in Ireland since June 2019, but it took years for the country to open its first medical cannabis clinic. It finally happened in November 2023, and the clinic now serves both patients admitted to the Medicinal Cannabis Access Programme, as well as others. Currently, only three conditions qualify for medical cannabis: spasticity associated with multiple sclerosis, intractable nausea and vomiting associated with chemotherapy, and severe treatment-resistant epilepsy.

https://hightimes.com/

Arizona Bill Would Legalize Psilocybin Service Centers, Add to Current Research Efforts

As Arizona lawmakers push for increased psilocybin research, some are looking to take things a step further by joining the ranks of other states that have ushered in legal psilocybin therapy. A group of nine bipartisan lawmakers in the state are sponsoring the newly introduced bill which would legalize psilocybin service centers, allowing those in Arizona to undergo therapy with the psychedelic substance under medical supervision, according to a Marijuana Moment report.  The bill would allow the Department of Human Services (DHS) to license these centers and would also establish the Arizona Psilocybin Advisory Board. The board would include members appointed by the governor and legislative leaders, like representatives of the attorney general’s office and DHS, military veterans, first responders, scientists with psilocybin experience and physicians, among other potential groups. Following in the footsteps of other states that have legalized psilocybin therapy, the board would need to establish training criteria for those working in psilocybin service centers and would also make recommendations on how the law is implemented while studying the science and policy developments related to psilocybin and other psychedelics. Board members would also be required to submit an annual report by July 31, 2025 and each year after regarding the status of “medical, psychological and scientific” studies surrounding the safety and efficacy of psilocybin. Members would also be required to report on a “long-term strategic plan” to ensure psychedelic-assisted therapy remains “safe, accessible and affordable” to those over 21. Medical directors of the therapy centers would be required to complete at least 132 hours of training under the approved program, including lessons on the historical and traditional use of psychedelics, safety and ethics, facilitation and preparation, administration and integration.  If passed, it would likely still be some time before Arizonans could expect to utilize the psilocybin services, however — the bill notes that the DHS would need to start accepting applications for the centers by Jan. 1, 2026. While the DHS would need to create rules for the program, the department would not be allowed to require specific eligible conditions for the services. The bill would also provide a significant boost to the state’s existing law focused on psilocybin research. Last year, the research was approved as part of an appropriations package specifically mandating further study into the medical potential of psilocybin pertaining to conditions like post-traumatic stress disorder (PTSD), depression, anxiety, long COVID symptoms and substance misuse disorder. The legislation puts $5 million in funding toward the research, and unlike many other previous studies, Arizona’s prospective research would not utilize lab-produced psilocybin. Rather, it would look at the use of whole mushrooms. More recently, an Arizona House committee approved another bill meant to protect the funding from being redistributed while the state deals with a budget deficit. Passing in an 11-3 vote, the legislation keeps the psychedelic research funds from going elsewhere until at least July 2026 so long as it gains final approval. Without the new legislation, research appropriations were set to expire this summer, which advocates argued was not enough time to properly conduct the research. Without the deadline extension, Dr. Dani Cabral, the principal investigator at IMA Clinical Research, said, “We are in a position here where we have $5 million, and few researchers will be awarded these funds, and they will have four months to complete a random control trial.” Sponsor Rep. Kevin Payne (R) similarly chimed in, pointing out that the research under the current timeline is essentially not possible. “What’s going to happen is they’re going to be halfway through the study and the money is going to run out and they’re not going to get paid at all,” he said. “So there won’t be anybody doing any studies unless we get this bill done.”

https://hightimes.com/

Former NFL Stars Hint at Presidential Bid With Weed Platform

Two-time Superbowl Champion Jim McMahon and All-Pro offensive lineman Kyle Turley are hinting at a run for the White House with a campaign built on passing a banking bill for legal marijuana businesses and creating awareness for the benefits of cannabis, according to a report from Fox Sports. McMahon, who played quarterback for the Chicago Bears, and Turley, a first-round pick by the New Orleans Saints in the 1998 NFL draft, are co-founders of the cannabis brand Revenant along with fellow professional football player Eben Britton. According to the company website, a “mutual respect and understanding of the healing principles the cannabis plant provides brought these gentlemen together and fuels [their] desire to share it with the world.” Last week, Turley visited New Hampshire to share his advocacy with Republican presidential candidate Nikki Haley and Democrat Dean Phillips, who has launched a long-shot bid to overtake President Joseph Biden in the race for the 2024 Democratic presidential nomination. During the visits, Turley reportedly talked up the benefits of cannabis and urged the candidates to support the Secure and Fair Enforcement and Regulation (SAFER) Banking Act, legislation that would give regulated cannabis companies access to traditional business banking services. Now, McMahon is teasing a potential run for president with Turley as his running mate, according to the Fox Sports report, with a platform based on cannabis advocacy and support for the marijuana banking bill. “We’re trying to get the message out about this cannabis plant and about fair banking,” McMahon told Fox News Digital. “We’re trying to bring awareness, not only to the cannabis industry but things that are going bad in this country. We’re going to make a little bit of noise. We might get some votes just for the cannabis part. We’re gonna have some fun with it. We’re gonna try and grow our brand and make people aware about this plant. We’ll see what happens.” The SAFER Banking Act was approved by the Senate Banking Committee in September and advanced for consideration by the full Senate. The bill is a revamped version of the Secure and Fair Enforcement (SAFE) Banking Act, a bill to provide cannabis companies access to traditional banking services that was passed by the House of Representatives seven times.  Under current federal law, providing financial services to cannabis companies is strictly regulated, leaving many businesses—particularly small, independent operators—without access to bank accounts, credit card processing and other financial services. As a result, many businesses operate exclusively or largely in cash, leaving operators and their customers and staff vulnerable to crime.  The SAFER Banking Act would remove the barriers to financial services for cannabis companies. Financial institutions would not be required to offer banking services to cannabis companies, but the bill discourages banks and credit unions from denying such services based on “personal beliefs or political motivations.” The measure also directs the U.S. Treasury’s Financial Crimes Enforcement Network to amend previous guidance on cannabis banking services within six months and for “depository institutions” to comply with the agency’s new regulations. In addition, to cannabis banking and advocacy, McMahon shared other themes of the hypothetical presidential campaign, touching on immigration, homelessness, taxation and spending policy. “I’d close the damn borders for one and then go find all the people that got in here illegally,” he said. “It’s ridiculous. We’re paying all this money as taxpayers, and it’s not helping us at all. We’re sending it all overseas, you know. Who knows where we’re sending it, but it’s not being used here in the states. “You look at California. They get the most money every year for homelessness, and they got the worst homeless population in the country or probably the world. There’s just so many things going wrong. We got to just stop the crazy spending and printing money and close our borders and let’s clean house.” McMahon played 15 years as an NFL quarterback, leading the Chicago Bears to the Superbowl championship following the 1985 season, later winning another ring with the Green Bay Packers. His experience with the pain and recovery associated with playing professional football led him to advocate for the NFL to change its policy surrounding cannabis use. “They need it for physical recovery,” McMahon recently told Forbes. “There’s no doubt about it. I mean, it’s the only neuroprotectant that has a patent on it. Why can’t they freely use that, rather than things that only mask the pain? That’s all they do. They don’t heal the body, they don’t help the body. They ruin your body, you get addicted to them, and they kill people, whereas cannabis has never killed anybody.” After being drafted by the Saints in 1998 and playing there for five seasons, Turley spent a year with the St. Louis Rams. A back injury prevented him from playing in 2004 and 2005, but he returned to NFL action to finish his career with two seasons on the Kansas City Chiefs. He has been a vocal cannabis advocate since he retired from the NFL and has also lobbied the league to lift its ban on cannabis.

https://hightimes.com/

19 Charged in Connection to Southern California Drug Trafficking Organization

Department of Justice indictments against an accused drug trafficking organization operating out of Southern California were unsealed Tuesday, revealing a vast criminal network which allegedly moved millions of dollars worth of drugs from California to Canada. According to a Department of Justice press release, the criminal network they targeted was responsible for trafficking hundreds of kilograms of cocaine, fentanyl and methamphetamine from Mexico into Los Angeles where they loaded it onto semi-trucks bound for Canada or other parts of the United States.  Various law enforcement organizations executed arrests and search warrants in Los Angeles; Sacramento, California; Miami; Odessa, Texas; Montreal; Toronto; and Calgary, Canada Tuesday morning with 30 search warrants served in Los Angeles alone. “Operation Dead Hand” as it was so dubbed by the feds was responsible for ten arrests in multiple cities across the United States and Canada. “Today’s charges and arrests across North America reflect the Justice Department’s close coordination with our Mexican and Canadian partners to disrupt international narcotics trafficking,” said Deputy Attorney General Lisa O. Monaco. “These cases provide yet another example of how our agents and prosecutors work side-by-side to uncover and dismantle organized criminal networks peddling and profiting from deadly drugs.” The many defendants charged in the two unsealed indictments are as follows: A notable name from that list is Robert Scoppa, whom the Department of Justice described as an alleged Canadian drug trafficker believed to be moving massive amounts of drugs on a regular basis with close ties to an Italian organized crime family. The other defendants were generally alleged to either be associated with Mexican crime groups involved in moving product over the southern border or handlers and dispatchers involved with a complex network of semi-truck drivers who made frequent border crossings into Canada via the Detroit Windsor Tunnel, the Buffalo Peace Bridge and the Blue Water Bridge.  “Drug trafficking is a global problem being driven by sophisticated, organized crime groups who put profits over people’s lives,” said U.S. Attorney Martin Estrada for the Central District of California. “Motivated by greed, these criminals destroy lives, devastate families, and wreak havoc in our community. But this case shows that we will collaborate with our international partners to bring these criminal networks to justice. Those who traffic in highly addictive and dangerous drugs will be held accountable.” Of the list of those indicted, 10 were arrested Tuesday, two were already in police custody and seven are considered to be fugitives. Those seven are as follows:  All those indicted face maximum penalties ranging from 40 years to life in prison. This organization has been accused of trafficking up to 845 kilograms of methamphetamine, 951 kilograms of cocaine, 20 kilograms of fentanyl, and 4 kilograms of heroin. The wholesale value of these drugs was estimated by the Department of Justice to be between $16-28 million and around $900,000 in cash was seized during this operation.  “Until today, the organized members of this conspiracy operated with impunity throughout the many thousands of miles that comprise the North American continent, poisoning communities along the way,” said Assistant Director in Charge Donald Alway of the FBI Los Angeles Field Office. “The strength of this partnership cannot be overstated. The agents and detectives on this case did an outstanding job of pooling resources and worked seamlessly across borders toward a mutual goal of putting this massive drug pipeline out of business.”

https://hightimes.com/

Veteran Oliver Carlin on a Journey To Help Spread Awareness With His Curative Mushrooms

Curative Mushrooms, a grow kit solution company owned by a Navy-veteran-turned-entrepreneur, Oliver Carlin, has emerged as a passionate advocate for the transformative power of mushrooms.  Oliver Carlin’s interest in mushrooms sprouted from his quest for holistic health solutions. Inspired by the extensive clinical studies on various mushroom strains, he started researching its benefits, to address issues such as depression, PTSD, anxiety, and addiction. As a Navy veteran with extensive experience in fitness activities, Carlin’s transition into the world of mushrooms was marked by his commitment to share this newfound knowledge with his blogs. In 2019, he founded Curative Mushrooms to simplify the process of growing mushrooms, enabling individuals to harness their health benefits without jumping from one so-called “expert video” to another or even buying costly equipment.  Recognizing the complexity of growing mushrooms, Carlin embarked on a mission to create foolproof grow kits. Despite facing challenges and investing significant time and resources, Carlin and his team developed a kit to grow mushrooms successfully within 30 days. In 2020, Curative Mushrooms created the simplest grow kit for beginners, allowing users to receive various mushroom spore syringes. The founder has also taken a step ahead to write a book on this for people who want a handy guide.  Carlin strives to provide clarity through his blogs, acknowledging the challenges of operating within legal boundaries. His goal is to educate people on their rights and provide a safe and legal way to grow mushrooms. He believes that once they understand their rights, they will be more likely to take action and grow their own mushrooms. Curative Mushrooms offers a range of grow bags for medicinal mushrooms like Lion’s Mane, Reishi, and Turkey Tail to name a few. The company has also packaged an all-in-one kit for cultivating “happy mushrooms.” They have continually improved their products, with grow bags capable of producing, on average, up to 60 dry grams of mushrooms per grow bag. The success of Curative Mushrooms is attributed to its engaged community across platforms like X, Facebook, and YouTube. “I feel that the success of Curative Mushrooms is largely due to the support of our community. I am grateful for this and will continue spreading awareness,” expresses Carlin. He remains focused on his advocacy, sharing personal stories of how mushrooms have transformed his life via social media channels.  Oliver Carlin is launching a new podcast series on Cannabis Radio with Co-Host Josh Nelson. The podcast called The Conscious Research Project will take listeners through a journey of exploring consciousness on levels that most never think of.

FAQ: How to use this hemp news hub

What topics does Chow420’s hemp news cover?

We aggregate and surface reputable coverage on hemp laws and enforcement, THC thresholds and policy proposals, cannabinoid products (CBD/Delta-8/hemp-derived THC), compliance, lab testing, recalls, and broader industry news.

Is this legal advice?

No. This page is for news and education. Hemp rules can change quickly and vary by state—always verify against the latest official guidance and consult qualified counsel for compliance decisions.

How do I evaluate hemp product safety claims?

Look for current third‑party COAs (Certificates of Analysis), clear ingredient labeling, and transparent sourcing. Be cautious with vague potency claims or missing lab reports.

Why do some articles mention Delta‑8 or “hemp-derived THC”?

These products often sit at the center of policy and enforcement changes. We track major updates so shoppers and brands can understand evolving requirements and market impacts.

How often is the news updated?

The crawler is scheduled to run daily. New items appear as sources publish updates.